A public offering of nearly 5 million shares of common stock pulled in $18.3 million in net proceeds for CareDx, higher than the company's expected proceeds of about $15.9 million. The money will be used as working capital, as well as to support general corporate functions.
Public offering brings in $18.3M for CareDx
Sign up for AABB SmartBrief
News about transfusion and cellular therapies
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.